Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study.

[1]  Yi-long Wu,et al.  KRAS Mutation in Patients with Lung Cancer: A Predictor for Poor Prognosis but Not for EGFR-TKIs or Chemotherapy , 2013, Annals of Surgical Oncology.

[2]  D. Dunkler,et al.  Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  J. Yeh,et al.  Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer. , 2012, Blood.

[4]  D. Ionescu,et al.  EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer. , 2012, Current oncology.

[5]  M. Tsao,et al.  A Systematic Review and Canadian Consensus Recommendations on the Use of Biomarkers in the Treatment of Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[6]  J. Rak,et al.  Oncogenic epidermal growth factor receptor up-regulates multiple elements of the tissue factor signaling pathway in human glioma cells. , 2010, Blood.

[7]  P. Comoglio,et al.  Genetic link between cancer and thrombosis. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  E. Lemarié,et al.  Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. , 2009, Clinical chemistry.

[9]  R. White,et al.  Venous Thromboembolism (VTE) in Patients with Cancer: Epidemiology and Risk Factors , 2009, Cancer investigation.

[10]  N. Blais.  Diagnosing, treating, and preventing venous thromboembolism in patients with cancer. , 2008, Clinical journal of oncology nursing.

[11]  Y. Gruel,et al.  Tissue Factor Expression in Non-small Cell Lung Cancer: Relationship with Vascular Endothelial Growth Factor Expression, Microvascular Density, and K-ras Mutation , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  H. Chew,et al.  The incidence of venous thromboembolism among patients with primary lung cancer , 2008, Journal of thrombosis and haemostasis : JTH.

[13]  W. Ageno,et al.  Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry , 2008, Haematologica.

[14]  A. Varki.  Trousseau's syndrome: multiple definitions and multiple mechanisms. , 2007, Blood.

[15]  V. Tagalakis,et al.  High Risk of Deep Vein Thrombosis in Patients with Non-small Cell Lung Cancer: A Cohort Study of 493 Patients , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[16]  F. Rosendaal,et al.  Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: results of a record linkage study , 2006, Journal of thrombosis and haemostasis : JTH.

[17]  M. Ladanyi,et al.  Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. , 2005, The Journal of molecular diagnostics : JMD.

[18]  M. Belting,et al.  Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Erwin G. Van Meir,et al.  PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. , 2005, Cancer research.

[20]  S. Shirasawa,et al.  Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. , 2005, Blood.

[21]  R. Fisher,et al.  Thromboembolism in hospitalized neutropenic cancer patients. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  L. Elting,et al.  Outcomes and cost of deep venous thrombosis among patients with cancer. , 2004, Archives of internal medicine.

[23]  S. Patierno,et al.  Tissue factor and fibrin in tumor angiogenesis. , 2004, Seminars in thrombosis and hemostasis.

[24]  Steven Patierno,et al.  Tissue factor, thrombin, and cancer. , 2003, Chest.

[25]  M. Prins,et al.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. , 2002, Blood.

[26]  K. Anagnostopoulou,et al.  A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients. , 2001, Molecular and cellular probes.

[27]  J. Olsen,et al.  Prognosis of cancers associated with venous thromboembolism. , 2000, The New England journal of medicine.

[28]  M. Levine.  Treatment of thrombotic disorders in cancer patients. , 1997, Haemostasis.

[29]  T. Luther,et al.  Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. , 1994, The Journal of clinical investigation.

[30]  J. Jeng,et al.  Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. , 1994, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[31]  N. Blais,et al.  Lung cancer associated venous thromboembolic disease: a comprehensive review. , 2012, Lung cancer.

[32]  K. Bailey,et al.  The association of active cancer with venous thromboembolism location: a population-based study. , 2011, Mayo Clinic proceedings.

[33]  P. Stein,et al.  Incidence of venous thromboembolism in patients hospitalized with cancer. , 2006, The American journal of medicine.

[34]  J. Levin,et al.  Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. , 1977, Medicine.

[35]  A. Trousseau.  Phlegmasia alba dolens. , 1865 .